Intranasal Drug Delivery System: A Review

Author:

Bava Bharat1,Sharma Kruti1,Yadav Vikas1

Affiliation:

1. Department of Pharmaceutics, A.R College of Pharmacy and G.H Patel Institute of Pharmacy, Vallabh Vidyanagar, Anand, 388120.

Abstract

Intranasal drug delivery is an innovative and non-invasive approach that has garnered increasing attention for its potential to enhance therapeutic efficacy in various disease conditions. This abstract provides a comprehensive overview of the advantages, challenges, and recent developments in intranasal drug delivery systems (INDDS). The unique anatomical features of the nasal cavity, including its extensive vascularization and large surface area, which allow for rapid absorption and bypass of the first-pass metabolism. These characteristics make the intranasal route particularly attractive for delivering drugs targeting the central nervous system, such as neurodegenerative disorders and migraine, as well as local treatments for sinusitis and allergic rhinitis. Furthermore, it can be delves into the various formulations utilized in INDDS, including solutions, suspensions, gels, micro emulsions, and nanoparticles. These formulations offer opportunities to improve drug solubility, stability, and bioavailability while allowing for sustained release and controlled drug release profiles. The article also highlights the challenges associated with intranasal drug delivery, such as limited drug permeability across the nasal epithelium, mucociliary clearance, and potential irritation of the nasal mucosa. Strategies to overcome these challenges, such as the use of permeation enhancers and mucoadhesive polymers, are discussed. These innovations have paved the way for novel drug delivery systems that show promising results in preclinical and clinical studies, offering significant potential for patient convenience and compliance. In conclusion, it can be said that intranasal drug delivery is a promising approach to improve therapeutic outcomes, especially for drugs targeting the central nervous system and local treatments. It underscores the importance of further research and development to optimize formulations, enhance drug permeability, and ensure safety and efficacy, ultimately opening new avenues for improved patient care and treatment strategies.

Publisher

A and V Publications

Reference13 articles.

1. Dharmendra Kumar and Mayank Bansal. Nasal Gel Formulation: A Review. The Global Journal of Pharmaceutical Research. 2012; 1(3): 1-8.

2. Santosh Thorat. Formulation and Product Development of Nasal Spray: An Overview. Scholars Journal of Applied Medical Sciences. 2016; 4(8D): 2976-2985.

3. Swatantra K.S. Kushwaha, Ravi Kumar Keshari, and A.K. Rai. Advances in nasal trans-mucosal drug delivery. Journal of Applied Pharmaceutical Science. 2011; 1(7): 21-28.

4. Anaisa Pires, Ana Fortuna, Gilberto Alves and Amilcar Falcao. Review on Intranasal Drug Delivery. J Pharm Pharmaceut Sci. 2009; 12(3): 288–311.

5. Rosamaria Lombardo, Teresa Musumeci, Claudia Carbone, and Rosario Pignatello. Nanotechnologies for intranasal drug delivery: an update of literature. Pharmaceutical Development and Technology. 2021; 1: 1-22.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3